Research peptide · Metabolic research
Amycretin
Also known as NNC0487-0111
A synthetic peptide described as a single-molecule agonist at both the GLP-1 receptor and the amylin receptors. No structure has been published for it.
- Compound type
- Research peptide
- Research area
- Metabolic
What it is
Amycretin is a synthetic peptide carrying the development code NNC0487-0111. It is described as a unimolecular agonist, meaning one chain engages two receptor systems that are usually addressed by separate molecules: the glucagon-like peptide-1 receptor and the amylin receptors.
Both targets are class B G protein-coupled receptors or complexes built on them. The GLP-1 receptor is a single polypeptide; the amylin receptors are complexes of the calcitonin receptor with one of three receptor activity-modifying proteins, and that pairing is what distinguishes amylin pharmacology from calcitonin pharmacology. A dual agonist of this kind is built by combining sequence elements that each receptor recognizes.
Structure and chemistry
No structure has been published for this compound. There is no PubChem record, no molecular formula, no reference mass and no sequence in the public literature, and none was located for this profile. Patent and nomenclature documents may contain the structure, but they were not consulted here and no claim is made about their contents.
In the absence of a published structure, nothing specific can be said about residue composition, cyclization, lipidation or salt form. Peptides in this class are typically larger than 3 kDa and are commonly modified at one or more positions to resist peptidases, but whether any of that applies to this molecule is not documented.
Analytical notes
Without a published formula or mass there is no expected ion to check a preparation against, which is the central analytical problem with this entry. Identity work therefore has to be self-contained: intact mass measurement by liquid chromatography with mass spectrometry to establish what the material is, enzymatic digestion and peptide mapping to derive sequence information, and amino acid analysis to confirm composition. Purity can still be assessed by reversed-phase HPLC relative to the main peak, but purity relative to an unverified identity is a weak statement.
Storage and handling in the laboratory
As supplied, peptide material of this type is a lyophilized powder, stored at -20 degrees Celsius, sealed and protected from light. The lyophilized state is hygroscopic, so a sealed vial should reach room temperature before opening.
Open questions in the literature
Everything structural is open: formula, mass, sequence, modification pattern and salt form are all unpublished. No cell or animal study of the compound was located either, so its receptor selectivity, potency and species profile are uncharacterized in the public preclinical literature. Until a structure is published, material carrying this name cannot be verified against any reference.
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.
